Medtech trade group AdvaMed wants the Biden administration to put the transport of medical supplies at the top of its list to address supply chain problems at ports worldwide. On his first day in office, Biden issued an executive order that promised, in part, to secure the pandemic supply chain and create a U.S. manufacturing base […]
AdvaMed
MedTech Innovator selects 50 startups for showcase and accelerator program
MedTech Innovator today revealed the 50 startups it selected to partake in its flagship showcase and accelerator program. The four-month program offers the startups visibility and access to leading manufacturers, providers, investors and other industry stakeholders, with up to $500,000 available in cash and in-kind prizes during the final competition at The MedTech Conference, powered […]
CMS delays Medicare payments for breakthrough devices until December
Medicare coverage for FDA-designated breakthrough medical devices will have to wait several more months, despite broad support. The Centers for Medicare and Medicaid Services (CMS) issued a final rule on Medicare Coverage of Innovative Technology (MCIT) in January, granting coverage for breakthrough devices the same day as their FDA approvals, for up to four years. Immediately […]
Women execs to discuss leadership during pandemic
AdvaMed’s Women’s Executive Network has scheduled a one-day leadership conference for Wednesday, May 19. Future of Medtech: Leading with Resilience, Agility and Empathy will be a virtual event featuring a range of executives from the medical device and corporate world to discuss issues pertaining to leadership throughout the COVID-19 pandemic. Get the full story on […]
CMS extends joint replacement pricing by 3 years
The Centers for Medicare and Medicaid Services (CMS) has extended bundled pricing for hip and knee replacements for three years. The final rule, published in the Federal Register, extends the “Comprehensive Care for Joint Replacement” cost-bundling program through Dec. 21, 2024. The cost-cutting program began in January 2016, when CMS required all hospitals in 67 geographic […]
AdvaMed launches medtech podcast
AdvaMed today announced the launch of a new podcast, MedTech POV. AdvaMed president and CEO Scott Whitaker hosts the podcast, which covers the intersection of medtech and policy from a variety of perspectives. Each episode will feature discussions with medtech and healthcare policy leaders on issues that are driving the day — from business to […]
CMS delays breakthrough device Medicare coverage
Medicare coverage for FDA-designated breakthrough medical devices will have to wait, despite broad support. The Centers for Medicare and Medicaid Services (CMS) issued a final rule in January granting coverage for breakthrough devices the same day as their FDA approvals. The rule was supposed to take effect March 12, but CMS has postponed the Medicare Coverage of […]
Biden to put $12B toward COVID testing
The Biden administration today pledged $10 billion for school COVID-19 screenings and $2.25 billion for screenings and diagnostic testing among underserved populations. The money is part of the $1.9 trillion American Rescue Plan Act that Biden signed into law last week. The Department of Health and Human Services will divvy up the $10 billion among […]
MedTech 100 roundup: Industry rebounds from massive dip
The medtech industry saw its largest fall in several months last week, but it has rebounded slightly after a couple of bad weeks. A strong start to 2021 hit a skid at the end of February and carried over into March, with MassDevice‘s MedTech 100 index hitting its lowest point on March 8 (102.16). It had […]
DTW Podcast: CEO Petrovic explains how Insulet is switching people to `Pods
Insulet CEO Shacey Petrovic says she didn’t jump immediately at the chance to join the company. In an interview with the DeviceTalks Weekly Podcast, Petrovic, who was serving as CEO of a women’s health company when CEO-Patrick Sullivan, her former boss at Cytyc, called her with an offer to serve as Insulet’s chief commercial officer […]
AdvaMed brass on Biden administration: So far, so good
In office barely two months, the Biden administration is winning high praise from leaders of the medtech trade group AdvaMed. That applies to the new administration’s use of the Defense Production Act for COVID supplies to its deliberation in choosing someone to lead the FDA. It doesn’t hurt that the $1.9 trillion pandemic relief bill […]
